Publications | Lucence 6/8

top of page

Publications

Filter by:

Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma

Publications

Aug 5, 2020

Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma

Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma

Ultrasensitive detection of diverse genomic alterations in hematological malignancies using a targeted amplicon-based sequencing approach

Publications

Jun 1, 2020

Ultrasensitive detection of diverse genomic alterations in hematological malignancies using a targeted amplicon-based sequencing approach

Ultrasensitive detection of diverse genomic alterations in hematological malignancies using a targeted amplicon-based sequencing approach

A discrete choice experiment (DCE) study evaluating preferences of Asian adults for inherited cancer risk testing.

Publications

May 25, 2020

A discrete choice experiment (DCE) study evaluating preferences of Asian adults for inherited cancer risk testing.

A discrete choice experiment (DCE) study evaluating preferences of Asian adults for inherited cancer risk testing.

Clinical utility of a liquid biopsy diagnostic approach in lung cancer using amplicon-based next-generation sequencing in parallel with allele-specific PCR.

Publications

May 25, 2020

Clinical utility of a liquid biopsy diagnostic approach in lung cancer using amplicon-based next-generation sequencing in parallel with allele-specific PCR.

Clinical utility of a liquid biopsy diagnostic approach in lung cancer using amplicon-based next-generation sequencing in parallel with allele-specific PCR.

Detection of actionable gene mutations in breast cancer by amplicon-based next-generation sequencing liquid biopsy

Publications

May 25, 2020

Detection of actionable gene mutations in breast cancer by amplicon-based next-generation sequencing liquid biopsy

Detection of actionable gene mutations in breast cancer by amplicon-based next-generation sequencing liquid biopsy

An ultrasensitive amplicon-based sequencing panel for noninvasive molecular testing of hematological malignancies using blood.

Publications

May 25, 2020

An ultrasensitive amplicon-based sequencing panel for noninvasive molecular testing of hematological malignancies using blood.

An ultrasensitive amplicon-based sequencing panel for noninvasive molecular testing of hematological malignancies using blood.

Ultrasensitive multiplex detection of structural rearrangements in ALK, RET, ROS1 and PD-L1 using a comprehensive next-generation sequencing assay.

Publications

May 25, 2020

Ultrasensitive multiplex detection of structural rearrangements in ALK, RET, ROS1 and PD-L1 using a comprehensive next-generation sequencing assay.

Ultrasensitive multiplex detection of structural rearrangements in ALK, RET, ROS1 and PD-L1 using a comprehensive next-generation sequencing assay.

Prognostic and predictive value of circulating tumour DNA (ctDNA) by amplicon-based next generation sequencing (NGS) of advanced pancreatic cancer (APC) in a phase I trial of oxaliplatin capecitabine and irinotecan (OXIRI) triplet chemotherapy.

Publications

Feb 4, 2020

Prognostic and predictive value of circulating tumour DNA (ctDNA) by amplicon-based next generation sequencing (NGS) of advanced pancreatic cancer (APC) in a phase I trial of oxaliplatin capecitabine and irinotecan (OXIRI) triplet chemotherapy.

Prognostic and predictive value of circulating tumour DNA (ctDNA) by amplicon-based next generation sequencing (NGS) of advanced pancreatic cancer (APC) in a phase I trial of oxaliplatin capecitabine and irinotecan (OXIRI) triplet chemotherapy.

Genetic Characterization of Vietnamese Patients with Hereditary Breast and Ovarian Cancer Syndrome

Publications

Nov 18, 2018

Genetic Characterization of Vietnamese Patients with Hereditary Breast and Ovarian Cancer Syndrome

Genetic Characterization of Vietnamese Patients with Hereditary Breast and Ovarian Cancer Syndrome

1

/

8

bottom of page